Document is current
Any future updates will be listed below
-
Authors
Neves, João Sérgio https://orcid.org/0000-0002-8173-8255
Leite, Ana Rita
Vale, Catarina
Marques, Pedro
Vasques-Nóvoa, Francisco
Leite-Moreira, Adelino
Ferreira, João Pedro
- License Information
-
More Information
Article History
Received: 17 May 2025
Accepted: 21 October 2025
First Online: 19 December 2025
Acknowledgements
: This publication is based on research using data from data contributors Eli Lilly that have been made available through Vivli. Vivli has not contributed to or approved, and Vivli and Eli Lilly are not in any way responsible for, the contents of this publication. An abstract reporting part of the results presented here was submitted to the Endocrine Society’s annual meeting ENDO 2025 (12 July 2025 to 15 July 2025, San Francisco, CA, USA).
: Data for this post hoc analysis was accessed through the Vivli (Center for Global Clinical Research Data) platform ( ) with the Vivli ID 00009964.
: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
: JSN reports having received consulting and speaker fees from AstraZeneca, BIAL, Boehringer Ingelheim, Eli Lilly and Novo Nordisk and speaker fees from Merck. ARL reports having received consulting fees from BIAL. PM received salary support from an educational grant by Janssen. FVN has received consultancy fees and/or research support from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Novartis and Ultragenyx. ALM has received research support from Boehringer Ingelheim, AstraZeneca, Novartis. JPF has received research support from Boehringer Ingelheim, AstraZeneca, Novartis, Bial, Salamandra and Bayer. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.
: JSN, ARL and JPF conceived and designed the study. JSN and ARL performed the data analysis. CV, PM, FVN, ALM and JPF provided methodological and statistical guidance. All authors contributed to the interpretation of the data. JSN and ARL drafted the first version of the manuscript. All authors critically revised the manuscript for important intellectual content and approved the final version to be submitted. JSN and ARL are the guarantors of this work and, as such, had full access to all the data in the analysis and take responsibility for the integrity of the data and the accuracy of the data analysis.
Free to read: This content has been made available to all.
